Literature DB >> 21984439

Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure.

Li-Yuan Wang1, Qing-Hua Meng, Zhi-Qiang Zou, Yu-Chen Fan, Jie Han, Zhao-Xia Qi, Jian Ge, Ai-Ling Xu, Si-Kui Wang, Kai Wang.   

Abstract

BACKGROUND: T helper (Th) 17 cells participate in the pathogenesis of liver diseases but their exact role in acute-on-chronic hepatitis B liver failure (ACHBLF) still remains obscure. AIMS: This present study was aimed to characterize the circulating Th17 cells and to analyze their association with disease progression in ACHBLF.
METHODS: This retrospective study consisted of 40 ACHBLF patients, 40 chronic hepatitis B (CHB) patients and 20 healthy controls. The frequency of peripheral Th17 cells and IL-17 mRNA level in peripheral blood mononuclear cells (PBMCs) were estimated by flow cytometry and relative quantitative real-time polymerase chain reaction.
RESULTS: We found that the frequency of peripheral Th17 cells, as well as the level of IL-17 mRNA in PBMCs, was significantly increased in ACHBLF patients compared with CHB patients and healthy controls. In ACHBLF patients, the frequency of Th17 cells was positively correlated with serum total bilirubin (r = 0.392, P = 0.012) and model for end-stage liver disease scores (r = 0.383, P = 0.015), but negatively correlated with prothrombin activity (r = -0.317, P = 0.046). The same trend was observed as for relative expression of IL-17. Furthermore, the frequency of Th17 cells and IL-17 mRNA level were significantly elevated in non-survivors compared with survivors in ACHBLF patients.
CONCLUSIONS: These results suggested that Th17 cells as well as IL-17 might be related with disease severity and prognosis in ACHBLF patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984439     DOI: 10.1007/s10620-011-1930-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements.

Authors:  Kiran Bambha; W Ray Kim; Walter K Kremers; Terry M Therneau; Patrick S Kamath; Russell Wiesner; Charles B Rosen; Jeff Thostenson; Joanne T Benson; E Rolland Dickson
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

2.  Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.

Authors:  Dongping Xu; Junliang Fu; Lei Jin; Hui Zhang; Chunbao Zhou; Zhengsheng Zou; Jing-Min Zhao; Bin Zhang; Ming Shi; Xilai Ding; Zirong Tang; Yang-Xin Fu; Fu-Sheng Wang
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

3.  Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease.

Authors:  X Hu; S Ma; X Huang; X Jiang; X Zhu; H Gao; M Xu; J Sun; W G H Abbott; J Hou
Journal:  J Viral Hepat       Date:  2011-06-01       Impact factor: 3.728

Review 4.  IL-17-producing T cells in lupus nephritis.

Authors:  S A Apostolidis; J C Crispín; G C Tsokos
Journal:  Lupus       Date:  2011-02       Impact factor: 2.911

5.  Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.

Authors:  Ji Yang; Yiwei Chu; Xue Yang; Di Gao; Lubing Zhu; Xinrong Yang; Linlin Wan; Ming Li
Journal:  Arthritis Rheum       Date:  2009-05

6.  Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

Authors:  Ji-Yuan Zhang; Zheng Zhang; Fang Lin; Zheng-Sheng Zou; Ruo-Nan Xu; Lei Jin; Jun-Liang Fu; Feng Shi; Ming Shi; Hui-Fen Wang; Fu-Sheng Wang
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

7.  Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.

Authors:  Jian Ge; Kai Wang; Qing-Hua Meng; Zhao-Xia Qi; Fan-Li Meng; Yu-Chen Fan
Journal:  J Clin Immunol       Date:  2009-09-10       Impact factor: 8.317

8.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

Authors:  Adnan Said; John Williams; Jeremy Holden; Patrick Remington; Ronald Gangnon; Alexandru Musat; Michael R Lucey
Journal:  J Hepatol       Date:  2004-06       Impact factor: 25.083

9.  Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.

Authors:  Q-F Sun; J-G Ding; D-Z Xu; Y-P Chen; L Hong; Z-Y Ye; M-H Zheng; R-Q Fu; J-G Wu; Q-W Du; W Chen; X-F Wang; J-F Sheng
Journal:  J Viral Hepat       Date:  2009-04-29       Impact factor: 3.728

10.  Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients.

Authors:  Qinghong Wang; Yanhua Zheng; Zemin Huang; Yi Tian; Jijun Zhou; Qing Mao; Yuzhang Wu; Bing Ni
Journal:  BMC Immunol       Date:  2011-04-14       Impact factor: 3.615

View more
  8 in total

1.  Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.

Authors:  Xue-Song Liang; Cheng-Zhong Li; Yin Zhou; Wei Yin; Ya-Yun Liu; Wen-Han Fan
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure.

Authors:  Hong Ye; Li-Yuan Wang; Jing Zhao; Kai Wang
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

3.  Impaired balance of T helper 17/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice.

Authors:  Xiao-Fei Sun; Lei Gu; Wen-Sheng Deng; Qing Xu
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

4.  Interleukin-6 upregulates Th17 response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure.

Authors:  Hee Yeon Kim; Joo Yeon Jhun; Mi-La Cho; Jong Young Choi; Jae Kyeong Byun; Eun-Kyung Kim; Seung Kew Yoon; Si Hyun Bae; Byung Ha Chung; Chul Woo Yang
Journal:  J Gastroenterol       Date:  2013-12-25       Impact factor: 7.527

Review 5.  Th17 cells in autoimmune and infectious diseases.

Authors:  José Francisco Zambrano-Zaragoza; Enrique Jhonatan Romo-Martínez; Ma de Jesús Durán-Avelar; Noemí García-Magallanes; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2014-08-03

Review 6.  Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis.

Authors:  Feliciano Chanana Paquissi
Journal:  Front Immunol       Date:  2017-09-28       Impact factor: 7.561

7.  TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.

Authors:  Chunli Xu; Yinping Lu; Xin Zheng; Xuemei Feng; Xuecheng Yang; Joerg Timm; Jun Wu; Baoju Wang; Mengji Lu; Dongliang Yang; Jia Liu
Journal:  Front Immunol       Date:  2017-11-23       Impact factor: 7.561

8.  Th17 cells over 5.9% at admission indicate poor prognosis in patients with HBV-related acute-on-chronic liver failure.

Authors:  Geng-Lin Zhang; Ting Zhang; Qi-Yi Zhao; Chao-Shuang Lin; Zhi-Liang Gao
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.